About
Brenton "Brent" Saunders is an American biopharma executive who has served as Chairman of the Board and CEO of Bausch + Lomb since March 2023, after previously leading Allergan, Actavis, Forest Laboratories, and Bausch + Lomb earlier in his career. He also holds multiple board and chair roles across healthcare, medical aesthetics, and digital health, including The Beauty Health Company, ARS Pharmaceuticals, Roam, Cambrian BioPharma, and Osmind. Public reporting also shows him making angel investments in health, mental-health, and crypto-adjacent startups.
Areas of interest
biopharmaeye healthmedical aestheticsmental healthdigital healthbiotechhealthcare AIconsumer healthcrypto